Could we view oncology from a completely fresh perspective? That’s the philosophy John Fleming wants to bring to GSK as it rethinks its approach to cancer
Despite going virtual, this year’s ASCO was full of groundbreaking research, as pharma finds new ways to harness the power of the immune system to fight cancer